337 related articles for article (PubMed ID: 12951576)
1. Trends in development and approval times for new therapeutics in the United States.
Reichert JM
Nat Rev Drug Discov; 2003 Sep; 2(9):695-702. PubMed ID: 12951576
[TBL] [Abstract][Full Text] [Related]
2. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
3. Canadian and US drug approval times and safety considerations.
Rawson NS; Kaitin KI
Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031
[TBL] [Abstract][Full Text] [Related]
4. Trends in antimicrobial drug development: implications for the future.
Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
[TBL] [Abstract][Full Text] [Related]
5. Economics of new oncology drug development.
DiMasi JA; Grabowski HG
J Clin Oncol; 2007 Jan; 25(2):209-16. PubMed ID: 17210942
[TBL] [Abstract][Full Text] [Related]
6. Accelerated approval of oncology products: a decade of experience.
Dagher R; Johnson J; Williams G; Keegan P; Pazdur R
J Natl Cancer Inst; 2004 Oct; 96(20):1500-9. PubMed ID: 15494600
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic recombinant proteins: trends in US approvals 1982 to 2002.
Reichert JM; Paquette C
Curr Opin Mol Ther; 2003 Apr; 5(2):139-47. PubMed ID: 12772503
[TBL] [Abstract][Full Text] [Related]
8. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2008; 21(1):36-43. PubMed ID: 18301808
[TBL] [Abstract][Full Text] [Related]
9. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
[TBL] [Abstract][Full Text] [Related]
10. Finding value in the U.S. Food and Drug Administration's Fast Track program.
Reichert JM; Rochon SL; Zhang BD
Drug News Perspect; 2009; 22(1):53-8. PubMed ID: 19209299
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic monoclonal antibodies: trends in development and approval in the US.
Reichert JM
Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
[TBL] [Abstract][Full Text] [Related]
12. New drug approval times and clinical evidence in Japan.
Ono S; Yoshioka C; Asaka O; Tamura K; Shibata T; Saito K
Contemp Clin Trials; 2005 Dec; 26(6):660-72. PubMed ID: 16122988
[TBL] [Abstract][Full Text] [Related]
13. Hasty approval, more withdrawals.
Prescrire Int; 2005 Aug; 14(78):144. PubMed ID: 16106597
[TBL] [Abstract][Full Text] [Related]
14. Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jul; 73(136):40453-63. PubMed ID: 18850678
[TBL] [Abstract][Full Text] [Related]
15. Can open-source R&D reinvigorate drug research?
Munos B
Nat Rev Drug Discov; 2006 Sep; 5(9):723-9. PubMed ID: 16915233
[TBL] [Abstract][Full Text] [Related]
16. Recent drug approvals from the US FDA and EMEA: what the future holds.
Pevarello P
Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069
[TBL] [Abstract][Full Text] [Related]
17. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
Fed Regist; 1998 May; 63(91):26191-3. PubMed ID: 10179336
[TBL] [Abstract][Full Text] [Related]
18. New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.
Rawson NS; Kaitin KI
Can J Clin Pharmacol; 2000; 7(2):97-101. PubMed ID: 10958705
[TBL] [Abstract][Full Text] [Related]
19. Controlling type I error rate for fast track drug development programmes.
Shih WJ; Ouyang P; Quan H; Lin Y; Michiels B; Bijnens L
Stat Med; 2003 Mar; 22(5):665-75. PubMed ID: 12587098
[TBL] [Abstract][Full Text] [Related]
20. Therapies for inborn errors of metabolism: what has the orphan drug act delivered?
Talele SS; Xu K; Pariser AR; Braun MM; Farag-El-Massah S; Phillips MI; Thompson BH; Coté TR
Pediatrics; 2010 Jul; 126(1):101-6. PubMed ID: 20566615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]